FDA Investigator Charles R Cote, RIC

Charles R Cote, RIC has conducted inspections on 326 sites in 20 countries as of 25 Jun 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
326
Last Inspection Date:
25 Jun 2013
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America, France, Norway, Canada, Romania, United Kingdom of Great Britain and Northern Ireland, Czechia, Sweden, Ireland, India, Finland, Italy, Australia, Slovenia, South Africa, Germany, Spain, New Zealand, Portugal, Belgium
FDA Investigators that have inspected at least one site in common with Charles R Cote, RIC:
Aaron L Dunbar, Aerial A Smith, Aimee J Edwin, Alan M Roberts, Alecia L Marson, Alfred P Pistorio, Allen F Hall, Allison A Aldridge, PhD, Amy L Mcintyre, Ana M Placencia, Anastasia M Shields, Anders W Evenson, Andrew J Barrowcliff, Angela E Glenn, Anita R Michael, Ann L Demarco, Anna Lazar, Anna M Brannen, Anthony A Charity, Anthony C Warchut, Anthony J Ladner, Anthony L Nicoli, April L Brown, April L Young, Azza Talaat, Barbara J Rincon, Barbara Janine Breithaupt, Barbara M Frazier, Blondell W Johnson, Bonita S Chester, Brandon C Heitmeier, Brenda W Uratani, PhD, Brian D Nicholson, Brian L Szcyubialka, Brooke K Higgins, Bruce Huang, Brunilda Torres, Burnell M Henry, Carl A Huffman, III, Carla A Norris, Carla J Lundi, CDR Ileana Barreto Pettit, Chad E Schmear, Charisse K Green, Charles L Zhou, Charles M Edwards, Charles R Bonapace, PhD, Chase Bourke, PhD, Cheryl A Clausen, Cheryl Love Harris, Chris A Sack, Christina A Castineyra, Christina A Miller, Christina Capacci Daniel, PhD, Christine W Twohy, Christopher D Leach, Christopher R Czajka, Concepcion Cruz, Jr, Conor J Mccarron, Constance L Richard, Constantin Y Philopoulos, Corey K Reno, Courtney R Ingalsbe, Courtney R Tiegs, Craig R Berger, Cynthia J Lee, MS, Cynthia M Goudeau, Dacia E Quick, Dale A Nyberg, Daniel L Obrzut, Darren D Holaday, Darren S Brown, David G Eng, David J Hafner, Deborah A Greco, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Deyaa Shaheen, Diane Kretschmer, Diane T Reindl, Dianna C Sonnenburg, Dina A Tallman, Dipesh K Shah, Doan T Nguyen, PharmD, Don H Bark, PhD, Donald L Lech, Douglas C Kovacs, Douglas J Snyder, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edmond J Baratta, Edmund F Mrak, Jr, Edward H Maticka, Edwin Melendez, Eileen A Liu, Elizabeth A Waltrip, Elizabeth D Connell, Elizabeth E Hart (ASCP), MT, Elizabeth P Mayer, Ellen C Weisensel, Emily E Markgraf, Eric A Breselow, Eric M Mueller, PharmD, Eric S Myskowski, Eric T Huebler, Erika V Butler, Erin D Mccaffery, Fannie M Harrell, Felix Maldonado, Francis A Guidry, Gajendiran Mahadevan, PhD, Gayle S Lawson, George T Allen, Jr, Geraldine D Sanders, Grace E Mcnally, Grant M Ruis, Gregory A Berg, Gregory R Brinsley, Gregory W Smith, Guerlain Ulysse, Gwyn G Dickinson, Hasan A Irier, PhD, Himanshu Gupta, PhD, Holly M Scott, Howard A Burmester, Hyojong Kwon, PhD, Ivan E Reyes, Ivis L Negron, J Benedict, Jacob W Reynolds, Jake T Lane, James C Maclaughlin, James K Ireland, James L Dunnie, Jr, James S Cartwright, Janis R Armedoriz, Jared P Stevens, Jasjeet K Sekhon, Javier E Santos, Jean M Bosenbecker, Jee Chung, PhD, Jeffery A Hangartner, Jeffry A Bernhardt, Jennifer A Longie Vollom, Jennifer Al Vollon, Jennifer L Gustavus, Jennifer L Huntington, Jennifer S Ness, Jeremy W Rotton, Jesse P Romenesko, Jessica L Barr, Jessica L Pressley, Joanne E King, Joel D Hustedt, Joey V Quitania, Jogy George, John A Iwen, John A Kadavil, PhD, John D White, John P Hermann, Jon C Polzine, Jonah S Ufferfilge, Jonathan G Gayechuway, Jonathan G Swoboda, Jonathan L Blonk, Jonathan R Campos, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Gonzalez, Jose Ohernandez Guzman, Jose R Hernandez, Joseph J Vannelli, Joseph M Edwin, Joshua P Wireman, Juan Rjimenez Garcia, Julianne C Mccullough, Junho Pak, Justin A Boyd, Justin J Jafferis, Justine Tomasso, Jyoti B Patel, PhD, Kailas Nagaraj, Kara A Scheibner, PhD, Karen L Kosar, Karen Takahashi, Kari M Johansen, Katherine A Clarke Girolamo, Katherine Szestypalow, Kathleen D Culver, Kathryn E Ogger, Kathryn M Mogen, Kathy Ac Girolamo, Keith C Rindahl, Kellia N Hicks, Kellie L Westerbuhr, Kelly I Anderson, Kenneth A Libertoski, Kenneth H Williams, Kent A Conforti, Kevin A Gonzalez, Kevin P Regan, Kim Lthomas Cruse, Kim M Wiegand, Kimberly W Destromp, Kristen D Evans, Kristy A Zielny, Kristy E Zuroski, Larae M Koopman, Laura Fontan, MS, Lauren E Skokan, Laurie B Frazier, Laurimer Kuilan Torres, Lawrence Harmon, Jr, LCDR Debra Emerson, LCDR Michael H Tollon, Leon R Stratman, Leonard H Lavi, Leonardm, Liatte Kreuger, PharmD, Libia M Lugo, Linda Thai, Linda V Weyer, Lisa M Bellows, Lisa M Lopez, Lori B Wikstrom, Lori M Newman, Lourdes Andujar, Lourdes Valentin Aponte, LT Kimberly M Hull, Luis A Dasta, Lydia I Rosas Marty, M Edith Snyder, Mada A Tautges, Makini Cobourne Duval, PhD, Margaret A Smithers, Margaret M Annes, Maria E Treadwell, Maria V Price, Marianela Aponte Cruz, Marie A Fadden, Marie F Morin, Mark E Parmon, Mark R Mcclain, Martin K Yau, PhD, Marvin D Jones, Maryann Ruff, Marybet Lopez Negron, Matthew B Casale, Matthew M Schuckmann, Maya M Davis, Meisha R Sampson, Meisha Waters, Melanie C Voges, Melanie M Walker, Melissa D Kalik, Melissa I Michurski, Melissa J Holz, Michael A Charles, Michael E Maselli, Michael F Skelly, PhD, Michael L Casner, Michael R Goga, Michael R Klapal, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle J Glembin, Miguel A Martinez Perez, Minh D Phan, Mohammed H Adam, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Mra Davism, Mra Digiuliod, Mra M Barbosar, Mra Mcculloughj, Mra Narulaa, Mra V Millarw, Muralidhara B Gavini, PhD, Nancy M Espinal, Natalie E Starczowski, Neal L Adams, Nealie C Newberger, Nebil A Oumer, Nicholas J Dubrovin, Nicholas L Paulin, Nicholas S Vasilakes, Nicholas T Domer, Nicholas Z Lu, Nicole C Shokatz, Nicole C Victoria, PhD, Nikki S Ramirez, Nina Ni, Norman K Starks, Omotunde O Osunsanmi, Paola E Lathrop, Parul M Patel, Patrick C Klotzbuecher, Patrick J Campbell, Patrick J Lynch, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Peter T Erlandson, Ralph H Vocque, Ramon A Hernandez, Ramon E Martinez, Raymond T Oji, Rebecca E Dombrowski, Rebecca L Mullikin, Regina T Brown, Richard E Needham, Richard K Vogel, Richard L Friedman, Rita K Kabaso, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert J Waldorf, Robert M Tillman, Rochelle L Cross, Rodney G Raiford, Roger F Zabinski, Ronald R Ruff, Ross J Grigsby, Russell J Glapion, Saied A Asbagh, Saleem A Akhtar, Salvatore N Randazzo, Samuel T Walker, Sandra A Boyd, Sandra A Hughes, Sandra D Wilson, Sandra Sejdinovic, Sangeeta M Khurana, PhD, Sarah A Palmer, Sarah E Mcmullen, Sarah E Rhoades, Scott A Golladay, Scott B Laufenberg, Scott L Schenian, Scott T Ballard, Sean R Marcsisin, Seneca D Toms, Sharon K Thoma, PharmD, Sharon L Matson, Shawn E Larson, Shirley J Berryman, Sneha S Patel, Steven A Gonzales, Steven Fong, MS, PhD, Susan F Laska, MS, Susan M Jackson, Susan M Miller, Susan M North, Susan T Hadman, Susanna E Ford, Suzanne M Crotty, Tanya L Keigley, Tara M Aikens, Tara M Carolfi, Tara M Humfeld, Tenzin Jangchup, Teresa I Navas, Terri L Dodds, Thomas J Arista, Timothy T Kapsala, Tina M Pawlowski, Tony T Yang, Torrance J Slayton, Travis S Bradley, Truong Xuan Nguyen (Andy), Tyson J Eldridge Stedman, Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Walden H Lee, Wayne T Smith, Wayne W Grundstrom, William E Keer, William Hallett, PhD, William P Fournier, Xiaohan Cai, PhD, Xiaokuang Lai, PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Yvonne E Lozano, Zachary A Bogorad, Zhaoyang Meng

Charles R Cote, RIC's Documents

Publish Date Document Type Title
March, 2000 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2000-03-10
May, 2001 EIR CIPAN-Companhia Industrial Produtora de Antibióticos, S.A. - EIR, 2001-05-30
September, 2010 EIR Scientific Protein Laboratories LLC - EIR, 2010-09-03
January, 2013 EIR Labor LS SE & Co. KG - EIR, 2013-01-28
June, 2012 EIR Accelerated Analytical - EIR, 2012-06-06
January, 2003 EIR Fermion Oy - EIR, 2003-01-28
August, 2012 FDA 483 Nephron Pharmaceuticals Corporation - Form 483, 2012-08-10
September, 2010 FDA 483 Scientific Protein Laboratories LLC - Form 483, 2010-09-03
September, 2004 EIR Foremost Farms USA - EIR, 2004-09-21
September, 2009 FDA 483 Johnson Creek Enterprises, LLC - Form 483, 2009-09-25
March, 2009 EIR Scientific Protein Laboratories LLC - EIR, 2009-03-04
April, 2012 EIR Scientific Protein Laboratories LLC - EIR, 2012-04-16
January, 2003 EIR Fermion Oy - EIR, 2003-01-31
July, 2001 EIR PPD Development, L.P. - EIR, 2001-07-18
August, 2003 EIR PPD Development, L.P. - EIR, 2003-08-05
May, 2009 FDA 483 IKI Mfg Co., Inc - Form 483, 2009-05-08
October, 2007 FDA 483 BioCascade Inc - Form 483, 2007-10-01
February, 2011 FDA 483 Zydus Lifesciences Limited - Form 483, 2011-02-03
February, 2002 FDA 483 Radix Laboratories Incorporated - Form 483, 2002-02-28
January, 2004 FDA 483 Response Erregierre SpA - Form 483R, 2004-08-20
April, 2002 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2002-04-29
July, 2012 FDA 483 Kleen Test Products Corporation - Form 483, 2012-07-18
June, 2013 FDA 483 University of North Dakota - Form 483, 2013-06-06
September, 2011 EIR ANI Pharmaceuticals, Inc. - EIR, 2011-09-16
July, 2001 EIR PPD Development, L.P. - EIR, 2001-07-27
September, 2012 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2012-09-13
July, 2006 FDA 483 Scientific Protein Laboratories LLC - Form 483, 2006-07-11
January, 2004 FDA 483 Response Erregierre SpA - Form 483R, 2004-05-20
January, 2012 EIR ANI Pharmaceuticals, Inc. - EIR, 2012-01-06
September, 2000 FDA 483 Mueller Sports Medicine, Inc - Form 483, 2000-09-21
September, 2011 FDA 483 American Flexpack, Inc. - Form 483, 2011-09-28
November, 2000 EIR ANI Pharmaceuticals, Inc. - EIR, 2000-11-01
March, 2009 FDA 483 Scientific Protein Laboratories LLC - Form 483, 2009-03-04
May, 2002 FDA 483 Kingchem Laboratories Inc. - Form 483, 2002-05-30
February, 2010 FDA 483 Cenexi - Laboratoires Thissen Sa - Form 483, 2010-02-11
January, 2001 EIR SAFC Inc - EIR, 2001-01-11
January, 2001 FDA 483 Response SAFC Inc - Form 483R, 2001-01-18
June, 2012 FDA 483 Accelerated Analytical - Form 483, 2012-06-06
June, 2001 EIR HOVIONE FARMACIÊNCIA, S.A. - EIR, 2001-06-05
January, 2004 EIR Erregierre SpA - EIR, 2004-04-27
January, 2004 EIR Erregierre SpA - EIR, 2004-04-27
August, 2009 FDA 483 Cambridge Major Laboratories, Inc. - Form 483, 2009-08-04
January, 2003 FDA 483 Geneva Laboratories, Inc. - Form 483, 2003-01-03
April, 2003 FDA 483 Curia Wisconsin, Inc. - Form 483, 2003-04-11
January, 2004 FDA 483 Tetrionics Inc - Form 483, 2004-01-15
May, 2002 EIR Kingchem Laboratories Inc. - EIR, 2002-05-30
June, 2011 EIR Scientific Protein Laboratories LLC - EIR, 2011-06-16
April, 2002 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2002-04-29
May, 2010 FDA 483 Coating Place Inc - Form 483, 2010-05-13
March, 2000 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2000-06-01
March, 2000 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2000-10-05
March, 2000 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2000-03-10
April, 2001 EIR Kendrick Laboratories, Inc. - EIR, 2001-04-06
February, 2009 FDA 483 BioCascade Inc - Form 483, 2009-02-20
March, 2011 FDA 483 H & P Industries, Inc. - Form 483, 2011-03-28
September, 2011 EIR ANIP Acquisition, Inc. - EIR, 2011-09-15
April, 2001 FDA 483 Kendrick Laboratories, Inc. - Form 483, 2001-04-06
December, 2009 FDA 483 Scientific Protein Laboratories LLC - Form 483, 2009-12-15
August, 2004 EIR Scientific Protein Laboratories LLC - EIR, 2004-08-09
January, 2001 FDA 483 Tetrionics Inc - Form 483, 2001-01-11
September, 2006 FDA 483 Coating Place Inc - Form 483, 2006-09-22
September, 2011 FDA 483 NORTHERN LABS, INC. - Form 483, 2011-09-23
September, 2006 EIR Coating Place Inc - EIR, 2006-09-22
June, 2001 FDA 483 Response HOVIONE FARMACIÊNCIA, S.A. - Form 483R, 2001-08-10
September, 2012 FDA 483 Cardinal Health 414, LLC - Form 483, 2012-09-26
October, 2003 EIR PPD Development, L.P. - EIR, 2003-10-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more